アブカムでは最適な動作のために Google Chrome など最新ブラウザでの閲覧を推奨します。
Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) corresponding to Human CD252/OX40L (C terminal).
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information.
Our Abpromise guarantee covers the use of ab76130 in the following tested applications.
|WB||1/10000 - 1/50000. Detects a band of approximately 50 kDa (predicted molecular weight: 30 kDa).|
The recombinant protein was expressed as a fusion protein.
ab76130 has not yet been referenced specifically in any publications.